• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

FDA-TRACK

The list below provides information on FDA’s performance measures and projects as aligned to FDA strategic priorities and program offices. This list enables you to view charts of performance data and progress on important projects and programs.

To view completed FDA-TRACK performance measures and projects view the Archive Index

Filter








Results

Number of results: 13

ItemProgramOfficeStrategic PlanStrategic Goal/Area
1Commissioner’s Fellowship ProgramOCSOffice of Scientific Professional DevelopmentOCS Strategic Priorities FY 2014Support an environment of scientific excellence, learning and integrity
2Centers of Excellence in Regulatory Science and Innovation (CERSI)OCSOffice of Regulatory Science and InnovationOCS Strategic Priorities FY 2014Support mission critical targeted research and raise the profile of regulatory science
3New Centers of Excellence in Regulatory Science and Innovation (CERSI)OCSOffice of Regulatory Science and InnovationOCS Strategic Priorities FY 2014Support mission critical targeted research and raise the profile of regulatory science
4Science Looking Forward ReportOCSOffice of Regulatory Science and InnovationOCS Strategic Priorities FY 2014Support mission critical targeted research and raise the profile of regulatory science
5FDA Program for Extramural Regulatory Science and Innovation (PERSI)OCSOffice of Regulatory Science and InnovationOCS Strategic Priorities FY 2014Support mission critical targeted research and raise the profile of regulatory science
6Office of the Chief Scientist Intramural Research GrantsOCSOffice of Regulatory Science and InnovationOCS Strategic Priorities FY 2014Support mission critical targeted research and raise the profile of regulatory science
7Women's Health Research RoadmapOCSOffice of Women's HealthOCS Strategic Priorities FY 2014Support mission critical targeted research and raise the profile of regulatory science
8Encouraging Women to Utilize FDA Safe Medication Use ResourcesOCSOffice of Women's HealthOCS Strategic Priorities FY 2014Support mission critical targeted research and raise the profile of regulatory science
9Percentage of Commissioner's Fellows who graduated and who were retainedOCSOffice of Scientific Professional DevelopmentOCS Strategic Priorities FY 2014Support an environment of scientific excellence, learning and integrity
10Number of projects, presentations, and manuscripts completed by Commissioner's FellowsOCSOffice of Scientific Professional DevelopmentOCS Strategic Priorities FY 2014Support an environment of scientific excellence, learning and integrity
11Number of FDA sponsored regulatory science training events, participants, and Continuing Education (CE) credits awardedOCSOffice of Scientific Professional DevelopmentOCS Strategic Priorities FY 2014Support an environment of scientific excellence, learning and integrity
12Number of FDA regulatory science training collaboration events, participants, and Continuing Education (CE) credits awardedOCSOffice of Scientific Professional DevelopmentOCS Strategic Priorities FY 2014Support an environment of scientific excellence, learning and integrity
13The Science of Sex and Gender in Human Health Modules III and IVOCSOffice of Women's HealthOCS Strategic Priorities FY 2014Support an environment of scientific excellence, learning and integrity

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information in the Archive Index may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.